Mantle Therapeutics Overview
- Year Founded
-
2023
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$8.3M
Mantle Therapeutics General Information
Description
Operator of a biotechnology research company intended to develop treatments for rare, fatal diseases that lack curative therapies. The company's platform spans multiple diseases and therapeutic technologies, enabling healthcare providers to cure the disease of their patients.
Contact Information
Website
www.mantletherapeutics.comCorporate Office
- 180 Varick Street
- New York, NY 10014
- United States
Corporate Office
- 180 Varick Street
- New York, NY 10014
- United States
Mantle Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 23-Sep-2026 | $8.3M | Completed | Startup | ||
| 2. Early Stage VC | 01-Dec-2025 | Completed | Startup | |||
| 1. Seed Round | 26-Nov-2024 | $3.5M | $3.5M | Completed | Startup |
Mantle Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Mantle Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Mantle Therapeutics Patents
Mantle Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026060349-A1 | Compositions for improving cell viability, mitochondrial function and frataxin expression, and methods of use thereof | Pending | 16-Sep-2024 |
Mantle Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Mantle Therapeutics Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AIN Ventures | Venture Capital | Minority | ||
| RTW Investments | Hedge Fund | Minority |
Mantle Therapeutics FAQs
-
When was Mantle Therapeutics founded?
Mantle Therapeutics was founded in 2023.
-
Where is Mantle Therapeutics headquartered?
Mantle Therapeutics is headquartered in New York, NY.
-
What is the size of Mantle Therapeutics?
Mantle Therapeutics has 4 total employees.
-
What industry is Mantle Therapeutics in?
Mantle Therapeutics’s primary industry is Drug Discovery.
-
Is Mantle Therapeutics a private or public company?
Mantle Therapeutics is a Private company.
-
What is the current valuation of Mantle Therapeutics?
The current valuation of Mantle Therapeutics is .
-
What is Mantle Therapeutics’s current revenue?
The current revenue for Mantle Therapeutics is .
-
How much funding has Mantle Therapeutics raised over time?
Mantle Therapeutics has raised $3.5M.
-
Who are Mantle Therapeutics’s investors?
AIN Ventures and RTW Investments have invested in Mantle Therapeutics.
-
When was Mantle Therapeutics acquired?
Mantle Therapeutics was acquired on 23-Sep-2026.
-
Who acquired Mantle Therapeutics?
Mantle Therapeutics was acquired by Lexeo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
